description, body, imageNovo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.Eshe Nelson2023-08-28T18:36:35.000Z[Collection]Drugs (Pharmaceuticals), Economic Conditions and Trends, Diabetes, Semaglutide (Drug), Gross Domestic Product, Novo Nordisk A/S, Denmark, Ozempic (Drug), Wegovy
